Sample Size: Upto 134 patients (Phase I: in cohort of 3-6 to test each dose level and a upto 48 patients to reach the expected MTD, 24 patients in each schedule of treatment arm; Phase II: 18 patients of each schedule at the first stage and 25 patients of each schedule at the second stage).